Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
324
324 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BPI-572270Phase 21 trial
Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- CKD-703Phase 21 trial
Chong Kun Dang Pharmaceutical · Advanced Solid Tumors, Non-Small Cell Lung Cancer
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- DanvatirsenAZD9150Phase 21 trial
AstraZeneca · Non-Small Cell Lung Cancer
- DC05F01Phase 21 trial
Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- DJI136Phase 21 trial
Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- DS-1103aPhase 21 trial
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DXC006Phase 21 trial
Hangzhou DAC Biotechnology Co., Ltd. · Small Cell Lung Cancer
- ECI830Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- ES102Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
- FF-10832Gemcitabine LiposomePhase 21 trial
Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer
- gavo-celPhase 21 trial
TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura
- GEN-725Phase 21 trial
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- GEN1042Phase 21 trial
Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- GFH925Phase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Advance Non-small Cell Lung Cancer
- GI-101Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-101APhase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- HMBD-001Phase 21 trial
Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- IDE161Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDE397Phase 21 trial
Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors
- IDE849Phase 21 trial
IDEAYA Biosciences · Small-cell Lung Cancer, Neuroendocrine Carcinomas, Solid Tumor Show to Express DLL3
- IDP-001Phase 21 trial
InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma
- ILKN421HPhase 21 trial
iLeukon Therapeutics, Inc. · Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
- IOV-4001Phase 21 trial
Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer
- IOV-5001Phase 21 trial
Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)
- IPH5201Phase 21 trial
Innate Pharma · Non Small Cell Lung Cancer
- JAB-2485Aurora A inhibitorPhase 21 trial
Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC
- JMT203Phase 21 trial
Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia
- JYP0015Phase 21 trial
Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
- KeynatinibTL007Phase 21 trial
Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NEO-201Phase 21 trial
Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer
- NHT102Phase 21 trial
Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)
- OBX-115Phase 21 trial
Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma
- OR502Phase 21 trial
OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm
- OSE-279Phase 21 trial
OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.